Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide for unexplained chronic cough
IRCT2013031212419N2Phase 3Completed
- Sponsor
- The budget will be funded by researchers.
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in chronic idiopathic cough (CIC), sponsored by The budget will be funded by researchers. Started Nov 2017; status: completed.
02
Drugs
budesonide
03
Conditions
chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on IRCT2013031212419N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013031212419N2.